Rapid Acting Analogues in Diabetes Mellitus Management

T he diabetes mellitus especially type 2 diabetes mellitus, a non communicable metabolic disorder gaining an epidemic stature in the present century with a prevalence of 177 million individuals worldwide in the year 2000. It is predicted to rise to at least 300 million individuals by 2025.1 In the history of diabetes the